PCM
JNJ icon

Palouse Capital Management’s Johnson & Johnson JNJ Stock Holding History

Palouse Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-117
Closed -$24.2K – 158
2025
Q4 		$24.2K Buy
+117
New +$23.1K 0.02% 125
2024
Q2 		– Sell
-5,047
Closed -$798K – 139
2024
Q1 		$798K Sell
5,047
-512
-9% -$81.5K 0.53% 56
2023
Q4 		$871K Sell
5,559
-624
-10% -$95.7K 0.62% 59
2023
Q3 		$963K Sell
6,183
-11,531
-65% -$1.9M 0.71% 58
2023
Q2 		$2.93M Sell
17,714
-1,153
-6% -$186K 2.05% 14
2023
Q1 		$2.92M Sell
18,867
-4,443
-19% -$717K 1.97% 15
2022
Q4 		$24.4M Sell
23,310
-1,468
-6% -$253K 1.69% 15
2022
Q3 		$4.05M Sell
24,778
-41
-0.2% -$6.94K 2.3% 10
2022
Q2 		$4.41M Sell
24,819
-169
-0.7% -$30.1K 2.18% 11
2022
Q1 		$4.43M Sell
24,988
-372
-1% -$63.3K 1.95% 16
2021
Q4 		$4.34M Sell
25,360
-1,181
-4% -$193K 1.85% 16
2021
Q3 		$4.29M Sell
26,541
-808
-3% -$138K 1.91% 17
2021
Q2 		$4.5M Sell
27,349
-250
-0.9% -$41.4K 1.97% 14
2021
Q1 		$4.54M Sell
27,599
-260
-0.9% -$42.1K 2% 17
2020
Q4 		$4.38M Sell
27,859
-2,288
-8% -$338K 2.32% 11
2020
Q3 		$4.49M Sell
30,147
-5,533
-16% -$819K 2.51% 9
2020
Q2 		$5.02M Sell
35,680
-2,037
-5% -$297K 2.65% 11
2020
Q1 		$4.95M Sell
37,717
-2,337
-6% -$332K 2.92% 7
2019
Q4 		$5.84M Buy
40,054
+1,048
+3% +$142K 2.21% 15
2019
Q3 		$5.05M Buy
+39,006
New +$5.14M 1.87% 25
2019
Q2 		– Sell
-31,794
Closed -$4.44M – 100
2019
Q1 		$4.44M Sell
31,794
-163
-0.5% -$21.8K 1.71% 27
2018
Q4 		$4.12M Sell
31,957
-461
-1% -$64.3K 1.63% 28
2018
Q3 		$4.48M Buy
32,418
+871
+3% +$116K 1.56% 27
2018
Q2 		$3.83M Buy
+31,547
New +$3.94M 1.3% 38
2016
Q3 		– Sell
-35,758
Closed -$4.34M – 96
2016
Q2 		$4.34M Sell
35,758
-763
-2% -$86.7K 1.76% 19
2016
Q1 		$3.95M Sell
36,521
-7,356
-17% -$762K 1.61% 25
2015
Q4 		$4.51M Sell
43,877
-1,227
-3% -$123K 1.76% 16
2015
Q3 		$4.21M Sell
45,104
-127
-0.3% -$12.3K 1.62% 19
2015
Q2 		$4.41M Buy
45,231
+14,555
+47% +$1.46M 1.55% 20
2015
Q1 		$3.09M Buy
30,676
+2,241
+8% +$228K 1.09% 37
2014
Q4 		$2.97M Buy
28,435
+1,620
+6% +$171K 1.05% 35
2014
Q3 		$2.86M Buy
26,815
+1,405
+6% +$146K 1.09% 33
2014
Q2 		$2.66M Sell
25,410
-625
-2% -$63.2K 0.98% 40
2014
Q1 		$2.56M Buy
26,035
+134
+0.5% +$12.4K 0.96% 40
2013
Q4 		$2.37M Sell
25,901
-4
-0% -$369 0.91% 40
2013
Q3 		$2.25M Sell
25,905
-135
-0.5% -$12.1K 0.91% 44
2013
Q2 		$2.24M Buy
+26,040
New +$2.21M 0.95% 37

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Palouse Capital Management's JNJ Position: Q1 2026 in Review

Palouse Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 117 shares — an estimated $24.2K sold.

Palouse Capital Management first reported a position in JNJ in Q2 2013 and held it in 37 quarters. The position peaked at $24.4M in Q4 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Palouse Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Palouse Capital Management sold 117 Johnson & Johnson shares in Q1 2026, an estimated $24.2K.
  • Palouse Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 37 quarters.
  • Palouse Capital Management's Johnson & Johnson position peaked at $24.4M in Q4 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Palouse Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.